Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.
Second Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.
Ultrasound Med Biol. 2021 Jun;47(6):1433-1447. doi: 10.1016/j.ultrasmedbio.2021.01.030. Epub 2021 Feb 27.
The Asian Federation of Societies for Ultrasound in Medicine and Biology aimed to provide information on techniques and indications for contrast-enhanced harmonic endoscopic ultrasound (CH-EUS), and to create statements including the level of recommendation. These statements are based on current scientific evidence reviewed by a Consensus Panel of 15 internationally renowned experts. The reliability of clinical questions was measured by agreement rates after voting. Six statements were made on techniques, including suitable contrast agents for CH-EUS, differences between contrast agents, setting of mechanical index, dual imaging and duration and phases for observation. Thirteen statements were made on indications, including pancreatic solid masses, pancreatic cancer staging, pancreatic cystic lesions and mural nodules, detection of subtle pancreatic lesions, gallbladder sludge and polyps, hepatic lesions, lymph nodes, subepithelial lesions, visceral vascular diseases, guidance of fine needle aspiration and evaluation for local therapy. These international expert consensus guidelines will assist endosonographers in conducting CH-EUS according to evidence-based information.
亚洲超声医学和生物学联合会旨在提供有关对比增强谐波内镜超声(CH-EUS)技术和适应证的信息,并制定包括推荐级别在内的声明。这些声明是基于共识专家组对 15 名国际知名专家审查的现有科学证据。通过投票后的一致率来衡量临床问题的可靠性。有 6 项关于技术的声明,包括 CH-EUS 适用的对比剂、对比剂的差异、机械指数的设置、双成像以及观察的持续时间和阶段。有 13 项关于适应证的声明,包括胰腺实性肿块、胰腺癌分期、胰腺囊性病变和壁结节、细微胰腺病变的检测、胆囊泥沙样结石和息肉、肝脏病变、淋巴结、黏膜下病变、内脏血管疾病、细针抽吸的引导以及局部治疗的评估。这些国际专家共识指南将帮助内镜超声医师根据循证信息进行 CH-EUS。